Polycystic Ovary Syndrome Renamed to Polyendocrine Metabolic Ovarian Syndrome

1-Minute Brief

The renaming aims to improve diagnosis and care for millions affected by the condition worldwide.

Key Facts

• Polycystic ovary syndrome (PCOS) has been officially renamed to polyendocrine metabolic ovarian syndrome (PMOS).
• The Endocrine Society stated the new name is intended to better reflect the underlying metabolic and endocrine features.
• The condition affects an estimated 170 million women globally, according to the Endocrine Society.
• More than three million women and girls in the UK are affected by the condition.
• The renaming follows a global effort involving medical experts and patient advocates.

What Happened

Medical organizations have officially changed the name of polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) following a coordinated international initiative.

Why It Matters

Advocates and medical professionals believe the new name will help reduce misdiagnosis and improve treatment by more accurately describing the condition's symptoms and causes.

What's Next

Healthcare providers and educational materials are expected to adopt the new terminology. Further guidance on diagnosis and treatment may be updated to reflect the change.